5. Sturgill-Koszycki, S., U.E. Schaible, and D.G. Russell. 1996. Mycobacterium-containing phagosomes are accessible to early endo- somes and reflect a transitional state in normal phagosome biogenesis. EMBO J. 15:6960–6968. 6. Keane, J., M.K. Balcewicz-Sablinska, H.G. Remold, G.L. Chupp, B.B. Meek, M.J. Fenton, and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298–304. 7. Park, J.S., M.H. Tamayo, M. Gonzales-Juarrero, I.M. Orme, and D.J. Ordway. 2006. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in mu- rine macrophages. J. Leukoc. Biol. 79:80–86. 8. Chen, M., H. Gan, and H.G. Remold. 2006. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J. Immunol. 176:3707–3716. 9. Kroemer, G., B. Dallaporta, and M. Resche-Rigon. 1998. The mito- chondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60:619–642. 10. Deshmukh, M., K. Kuida, and E.M. Johnson. 2000. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J. Cell Biol. 150:131–143. 11. Duvall, E., and A.H. Wyllie. 1986. Death and the cell. Immunol. Today. 7:115–119. 12. Keane, J., H.G. Remold, and H. Kornfeld. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164:2016–2020. 13. Braunstein, M., B.J. Espinose, J. Chan, J.T. Belisle, and W.R. Jacobs. 2003. SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol. Microbiol. 48:453–464. 14. Schaible, U.E., F. Winau, P. Sieling, K. Fischer, H.L. Collins, K. Hagens, R.L. Modlin, V. Brinkmann, and S.H. Kaufmann. 2003. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat. Med. 9:1039–1046. 15. Fratazzi, C., R.D. Arbeit, C. Carini, and H.G. Remold. 1997. Programmed cell death of Mycobacterium avium serovar 4 - infected hu- man macrophages prevents the mycobacteria from spreading and in- duces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158:4320–4327. 16. Molloy, A., P. Laochumroonvorapong, and G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intra- cellular bacillus Calmette-Guérin. J. Exp. Med. 180:1499–1509. 17. Lee, J., H.G. Remold, M.H. Ieung, and H.K. Kornfeld. 2006. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J. Immunol. 176:4267–4274. 18. Sly, L.M., S.M. Hingley-Wilson, N.E. Reiner, and W.R. McMaster. 2003. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J. Immunol. 170:430–437. 19. Green, D.R., and G. Kroemer. 2004. The pathophysiology of mito- chondrial cell death. Science. 305:626–629. 20. Budd, R.C. 2001. Activation-induced cell death. Curr. Opin. Immunol. 13:356–362. 21. Vaux, D.L., and A. Strasser. 1996. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:2239–2244. 22. Thornberry, N.A., and Y. Lazebnik. 1998. Caspases: enemies within. Science. 281:1312–1316. 23. Rizzuto, R., P. Pinton, D. Ferrari, M. Chami, G. Szabadhai, P.J. Magalhaes, F. DiVirgilio, and T. Pozzan. 2003. Calcium and apoptosis: facts and hypotheses. Oncogene. 22:8619–8627. 24. Green, D.R. 2005. Apoptotic pathways: ten minutes to dead. Cell. 121:671–674. 25. Frigui, W., D. Bottal, L. Majlessi, M. Monot, E. Josselin, P. Bridin, T. Garnier, B. Gicquel, C. Martin, C. Leclerc, S. T. Cole, and R. Brosch. 2008. Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by Phop. PLoS Pathog. 4:e33. 26. Gan, H., X. He, L. Duan, E. Mirabile-Levens, H. Kornfeld, and H.G. Remold. 2005. Enhancement of antimycobacterial activity of macro- 2800 phages by stabilization of inner mitochondrial membrane potential. J. Infect. Dis. 191:1292–1300. 27. Duan, L., H. Gan, J. Arm, and H.G. Remold. 2001. Cytosolic phos- pholipase A2 participates with TNF-alpha in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra. J. Immunol. 166:7469–7476. 28. Kudo, I., and M. Murakami. 2002. Phosphatase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69:3–58. 29. Wu, Y.L., X.R. Jiang, A.C. Newland, and S.M. Kelsey. 1998. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J. Immunol. 160:5929–5936. 30. Wissing, D., H. Mouritzen, M. Egeblad, G.G. Poirier, and M. Jaattela. 1997. Involvement of caspase-dependent activation of cytosolic phos- pholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:5073–5077. 31. Serhan, C.N. 1997. Lipoxins and novel aspirin-triggered 15-epi-lipox- ins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins. 53:107–137. 32. Godson, C., S. Mitchell, K. Harvey, N.A. Petasis, N. Hogg, and H.R. Brady. 2000. Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164:1663–1667. 33. Borgeat, P., and P.H. Naccache. 1990. Biosynthesis and biological ac- tivity of leukotriene B4. Clin. Biochem. 23:459–468. 34. Rocca, B., and G.A. FitzGerald. 2002. Cyclooxygenases and prostaglan- dins: shaping up the immune response. Int. Immunopharmacol. 2:603–630. 35. Murakami, M., H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh-Ishi, and I. Kudo. 2000. Regulation of prostaglandin E2 biosynthesis by inducible membrane- associated prostaglandin E2 synthase that acts in concert with cyclooxy- genase-2. J. Biol. Chem. 275:32783–32792. 36. Tilley, S.L., T.M. Coffman, and B.H. Coller. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:15–23. 37. Zamora, R., H. Bult, and A.G. Herman. 1998. The role of prostaglan- din E2 and nitric oxide in cell death in J774 murine macrophages. Eur. J. Pharmacol. 349:307–315. 38. Bafica, A., C.A. Scanga, C. Serhan, F. Machado, S. White, A. Sher, and A. Aliberti. 2005. Host control of Mycobacterium tuberculosis is regu- lated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115:1601–1606. 39. Levy, B.D., G.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2:612–619. 40. Clària, J. 2003. Cycolooxygenase-2 biology. Curr. Pharm. Des. 9:2177–2190. 41. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J.L. Vayssiere, P.X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661–1672. 42. Trebino, C.E., J.L. Stock, C.P. Gibbons, B.M. Naiman, T.S. Wachtmann, J.P. Umland, K. Pandher, J.-M. Lapoite, S. Saha, M.L. Roach, et al. 2003. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA. 100:9044–9049. 43. Nataraj, C., D.W. Thomas, S.L. Tilley, M.T. Nguyen, R. Mannon, B.H. Koller, and T.M. Coffman. 2001. Receptors for prostaglandin E (2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 108:1229–1235. 44. Stock, J.L., K. Shinjo, J. Burkhardt, M. Roach, K. Taniguchi, T. Ishikawa, H.-S. Kim, P.J. Flannery, T.M. Coffman, J.D. McNeish, and L.P. Audoly. 2001. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J. Clin. Invest. 107:325–331. 45. Tilley, S.L., L.P. Audoly, E.H. Hicks, H.-S. Kim, P. Flannery, T.M. Coffman, and B.H. Koller. 1999. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J. Clin. Invest. 103:1539–1545. 46. Fleming, E.F., K. Athirakul, M.I. Oliverio, M. Key, J. Goulet, B.H. Koller, and T.M. Coffman. 1998. Urinary concentrating function in LIPID MEDIATORS IN MTB INFECTION | Chen et al.